Jefferies Downgrades Tango Therapeutics to Hold, Raises Price Target to $27
Benzinga Newsdesk 5 months ago
NewsDowngradesPrice TargetAnalyst Ratings
Jefferies analyst Maury Raycroft downgrades Tango Therapeutics (NASDAQ:TNGX) from Buy to Hold and raises the price target from $18 to $27.
Jefferies analyst Maury Raycroft downgrades Tango Therapeutics (NASDAQ:TNGX) from Buy to Hold and raises the price target from $18 to $27.